Fingerprint
Dive into the research topics of 'Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): An adaptive, dose-ranging, randomised, phase 2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): An adaptive, dose-ranging, randomised, phase 2 study
Krzysztof Selmaj, David K B Li, Hans Peter Hartung, Bernhard Hemmer, Ludwig Kappos, Mark S. Freedman, Olaf Stüve, Peter Rieckmann, Xavier Montalban, Tjalf Ziemssen, Lixin Zhang Auberson, Harald Pohlmann, Francois Mercier, Frank Dahlke, Erik Wallström
Research output: Contribution to journal › Article › peer-review
211
Scopus
citations